Pamela Wedel

Plus aucun poste en cours

Health Technology

Consumer Services

Anciens postes connus de Pamela Wedel

Sociétés	Poste	Début	Fin
SPRUCE BIOSCIENCES, INC.	Directeur des opérations	-	-
SPRUCE BIOSCIENCES, INC.	Corporate Officer/Principal	-	11/10/2022
Amplyx Pharmaceuticals, Inc. Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA.	Directeur Technique/Scientifique/R&D	-	-

San Diego State University

Undergraduate Degree

Internationale

Etats-Unis

Opérationnelle

Chief Operating Officer	1
Corporate Officer/Principal	1
Chief Tech/Sci/R&D Officer	1

Sectorielle

Health Technology	3
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
SPRUCE BIOSCIENCES, INC.	Health Technology

Entreprise privées	1
Amplyx Pharmaceuticals, Inc. Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA.	Health Technology

Entreprise privées

Health Technology